Global Opioid-induced Constipation Market Professional Survey Report 2018

March 2018 | 123 pages | ID: G819B28EB1AEN
QYResearch

Abstracts

This report studies Opioid-induced Constipation in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• AstraZeneca
• Takeda Pharmaceutical
• Valeant Pharmaceuticals International
• Abbott
• Bayer
• Boehringer Ingelheim
• C.B. Fleet
• Cosmo Pharmaceuticals
• Daewoong
• Daiichi Sankyo
• GlaxoSmithKline
• Ironwood Pharmaceuticals
• Johnson & Johnson
• Merck
• Mundipharma
• Nektar Therapeutics
• Pfizer
• Progenics Pharmaceuticals
• Shionogi
• SLA Pharma
• Sucampo
• Synergy Pharmaceuticals
• Theravance

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Solid
• Liquid

By Application, the market can be split into

• Drugstore
• Hospital
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Opioid-induced Constipation Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF OPIOID-INDUCED CONSTIPATION

1.1 Definition and Specifications of Opioid-induced Constipation
  1.1.1 Definition of Opioid-induced Constipation
  1.1.2 Specifications of Opioid-induced Constipation
1.2 Classification of Opioid-induced Constipation
  1.2.1 Solid
  1.2.2 Liquid
1.3 Applications of Opioid-induced Constipation
  1.3.1 Drugstore
  1.3.2 Hospital
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF OPIOID-INDUCED CONSTIPATION

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Opioid-induced Constipation
2.3 Manufacturing Process Analysis of Opioid-induced Constipation
2.4 Industry Chain Structure of Opioid-induced Constipation

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF OPIOID-INDUCED CONSTIPATION

3.1 Capacity and Commercial Production Date of Global Opioid-induced Constipation Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Opioid-induced Constipation Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Opioid-induced Constipation Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Opioid-induced Constipation Major Manufacturers in 2017

4 GLOBAL OPIOID-INDUCED CONSTIPATION OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Opioid-induced Constipation Capacity and Growth Rate Analysis
  4.2.2 2017 Opioid-induced Constipation Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Opioid-induced Constipation Sales and Growth Rate Analysis
  4.3.2 2017 Opioid-induced Constipation Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Opioid-induced Constipation Sales Price
  4.4.2 2017 Opioid-induced Constipation Sales Price Analysis (Company Segment)

5 OPIOID-INDUCED CONSTIPATION REGIONAL MARKET ANALYSIS

5.1 North America Opioid-induced Constipation Market Analysis
  5.1.1 North America Opioid-induced Constipation Market Overview
  5.1.2 North America 2013-2018E Opioid-induced Constipation Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Opioid-induced Constipation Sales Price Analysis
  5.1.4 North America 2017 Opioid-induced Constipation Market Share Analysis
5.2 China Opioid-induced Constipation Market Analysis
  5.2.1 China Opioid-induced Constipation Market Overview
  5.2.2 China 2013-2018E Opioid-induced Constipation Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2013-2018E Opioid-induced Constipation Sales Price Analysis
  5.2.4 China 2017 Opioid-induced Constipation Market Share Analysis
5.3 Europe Opioid-induced Constipation Market Analysis
  5.3.1 Europe Opioid-induced Constipation Market Overview
  5.3.2 Europe 2013-2018E Opioid-induced Constipation Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2013-2018E Opioid-induced Constipation Sales Price Analysis
  5.3.4 Europe 2017 Opioid-induced Constipation Market Share Analysis
5.4 Southeast Asia Opioid-induced Constipation Market Analysis
  5.4.1 Southeast Asia Opioid-induced Constipation Market Overview
  5.4.2 Southeast Asia 2013-2018E Opioid-induced Constipation Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2013-2018E Opioid-induced Constipation Sales Price Analysis
  5.4.4 Southeast Asia 2017 Opioid-induced Constipation Market Share Analysis
5.5 Japan Opioid-induced Constipation Market Analysis
  5.5.1 Japan Opioid-induced Constipation Market Overview
  5.5.2 Japan 2013-2018E Opioid-induced Constipation Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2013-2018E Opioid-induced Constipation Sales Price Analysis
  5.5.4 Japan 2017 Opioid-induced Constipation Market Share Analysis
5.6 India Opioid-induced Constipation Market Analysis
  5.6.1 India Opioid-induced Constipation Market Overview
  5.6.2 India 2013-2018E Opioid-induced Constipation Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Opioid-induced Constipation Sales Price Analysis
  5.6.4 India 2017 Opioid-induced Constipation Market Share Analysis

6 GLOBAL 2013-2018E OPIOID-INDUCED CONSTIPATION SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Opioid-induced Constipation Sales by Type
6.2 Different Types of Opioid-induced Constipation Product Interview Price Analysis
6.3 Different Types of Opioid-induced Constipation Product Driving Factors Analysis
  6.3.1 Solid of Opioid-induced Constipation Growth Driving Factor Analysis
  6.3.2 Liquid of Opioid-induced Constipation Growth Driving Factor Analysis

7 GLOBAL 2013-2018E OPIOID-INDUCED CONSTIPATION SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Opioid-induced Constipation Consumption by Application
7.2 Different Application of Opioid-induced Constipation Product Interview Price Analysis
7.3 Different Application of Opioid-induced Constipation Product Driving Factors Analysis
  7.3.1 Drugstore of Opioid-induced Constipation Growth Driving Factor Analysis
  7.3.2 Hospital of Opioid-induced Constipation Growth Driving Factor Analysis
  7.3.3 Others of Opioid-induced Constipation Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF OPIOID-INDUCED CONSTIPATION

8.1 AstraZeneca
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 AstraZeneca 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AstraZeneca 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.2 Takeda Pharmaceutical
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Takeda Pharmaceutical 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Takeda Pharmaceutical 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.3 Valeant Pharmaceuticals International
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Valeant Pharmaceuticals International 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Valeant Pharmaceuticals International 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.4 Abbott
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Abbott 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Abbott 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.5 Bayer
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Bayer 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Bayer 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.6 Boehringer Ingelheim
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Boehringer Ingelheim 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Boehringer Ingelheim 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.7 C.B. Fleet
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 C.B. Fleet 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 C.B. Fleet 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.8 Cosmo Pharmaceuticals
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Cosmo Pharmaceuticals 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Cosmo Pharmaceuticals 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.9 Daewoong
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Daewoong 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Daewoong 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.10 Daiichi Sankyo
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Daiichi Sankyo 2017 Opioid-induced Constipation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Daiichi Sankyo 2017 Opioid-induced Constipation Business Region Distribution Analysis
8.11 GlaxoSmithKline
8.12 Ironwood Pharmaceuticals
8.13 Johnson & Johnson
8.14 Merck
8.15 Mundipharma
8.16 Nektar Therapeutics
8.17 Pfizer
8.18 Progenics Pharmaceuticals
8.19 Shionogi
8.20 SLA Pharma
8.21 Sucampo
8.22 Synergy Pharmaceuticals
8.23 Theravance

9 DEVELOPMENT TREND OF ANALYSIS OF OPIOID-INDUCED CONSTIPATION MARKET

9.1 Global Opioid-induced Constipation Market Trend Analysis
  9.1.1 Global 2018-2025 Opioid-induced Constipation Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Opioid-induced Constipation Sales Price Forecast
9.2 Opioid-induced Constipation Regional Market Trend
  9.2.1 North America 2018-2025 Opioid-induced Constipation Consumption Forecast
  9.2.2 China 2018-2025 Opioid-induced Constipation Consumption Forecast
  9.2.3 Europe 2018-2025 Opioid-induced Constipation Consumption Forecast
  9.2.4 Southeast Asia 2018-2025 Opioid-induced Constipation Consumption Forecast
  9.2.5 Japan 2018-2025 Opioid-induced Constipation Consumption Forecast
  9.2.6 India 2018-2025 Opioid-induced Constipation Consumption Forecast
9.3 Opioid-induced Constipation Market Trend (Product Type)
9.4 Opioid-induced Constipation Market Trend (Application)

10 OPIOID-INDUCED CONSTIPATION MARKETING TYPE ANALYSIS

10.1 Opioid-induced Constipation Regional Marketing Type Analysis
10.2 Opioid-induced Constipation International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Opioid-induced Constipation by Region
10.4 Opioid-induced Constipation Supply Chain Analysis

11 CONSUMERS ANALYSIS OF OPIOID-INDUCED CONSTIPATION

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL OPIOID-INDUCED CONSTIPATION MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Opioid-induced Constipation
Table Product Specifications of Opioid-induced Constipation
Table Classification of Opioid-induced Constipation
Figure Global Production Market Share of Opioid-induced Constipation by Type in 2017
Figure Solid Picture
Table Major Manufacturers of Solid
Figure Liquid Picture
Table Major Manufacturers of Liquid
Table Applications of Opioid-induced Constipation
Figure Global Consumption Volume Market Share of Opioid-induced Constipation by Application in 2017
Figure Drugstore Examples
Table Major Consumers in Drugstore
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Opioid-induced Constipation by Regions
Figure North America Opioid-induced Constipation Market Size (Million USD) (2013-2025)
Figure China Opioid-induced Constipation Market Size (Million USD) (2013-2025)
Figure Europe Opioid-induced Constipation Market Size (Million USD) (2013-2025)
Figure Southeast Asia Opioid-induced Constipation Market Size (Million USD) (2013-2025)
Figure Japan Opioid-induced Constipation Market Size (Million USD) (2013-2025)
Figure India Opioid-induced Constipation Market Size (Million USD) (2013-2025)
Table Opioid-induced Constipation Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Opioid-induced Constipation in 2017
Figure Manufacturing Process Analysis of Opioid-induced Constipation
Figure Industry Chain Structure of Opioid-induced Constipation
Table Capacity and Commercial Production Date of Global Opioid-induced Constipation Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Opioid-induced Constipation Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Opioid-induced Constipation Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Opioid-induced Constipation Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Opioid-induced Constipation 2013-2018E
Figure Global 2013-2018E Opioid-induced Constipation Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Opioid-induced Constipation Market Size (Value) and Growth Rate
Table 2013-2018E Global Opioid-induced Constipation Capacity and Growth Rate
Table 2017 Global Opioid-induced Constipation Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Opioid-induced Constipation Sales (K Units) and Growth Rate
Table 2017 Global Opioid-induced Constipation Sales (K Units) List (Company Segment)
Table 2013-2018E Global Opioid-induced Constipation Sales Price (USD/Unit)
Table 2017 Global Opioid-induced Constipation Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Opioid-induced Constipation 2013-2018E
Figure North America 2013-2018E Opioid-induced Constipation Sales Price (USD/Unit)
Figure North America 2017 Opioid-induced Constipation Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Opioid-induced Constipation 2013-2018E
Figure China 2013-2018E Opioid-induced Constipation Sales Price (USD/Unit)
Figure China 2017 Opioid-induced Constipation Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Opioid-induced Constipation 2013-2018E
Figure Europe 2013-2018E Opioid-induced Constipation Sales Price (USD/Unit)
Figure Europe 2017 Opioid-induced Constipation Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Opioid-induced Constipation 2013-2018E
Figure Southeast Asia 2013-2018E Opioid-induced Constipation Sales Price (USD/Unit)
Figure Southeast Asia 2017 Opioid-induced Constipation Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Opioid-induced Constipation 2013-2018E
Figure Japan 2013-2018E Opioid-induced Constipation Sales Price (USD/Unit)
Figure Japan 2017 Opioid-induced Constipation Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Opioid-induced Constipation 2013-2018E
Figure India 2013-2018E Opioid-induced Constipation Sales Price (USD/Unit)
Figure India 2017 Opioid-induced Constipation Sales Market Share
Table Global 2013-2018E Opioid-induced Constipation Sales (K Units) by Type
Table Different Types Opioid-induced Constipation Product Interview Price
Table Global 2013-2018E Opioid-induced Constipation Sales (K Units) by Application
Table Different Application Opioid-induced Constipation Product Interview Price
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2017 AstraZeneca Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 AstraZeneca Opioid-induced Constipation Business Region Distribution
Table Takeda Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2017 Takeda Pharmaceutical Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Takeda Pharmaceutical Opioid-induced Constipation Business Region Distribution
Table Valeant Pharmaceuticals International Information List
Table Product A Overview
Table Product B Overview
Table 2015 Valeant Pharmaceuticals International Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Valeant Pharmaceuticals International Opioid-induced Constipation Business Region Distribution
Table Abbott Information List
Table Product A Overview
Table Product B Overview
Table 2017 Abbott Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Abbott Opioid-induced Constipation Business Region Distribution
Table Bayer Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bayer Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bayer Opioid-induced Constipation Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2017 Boehringer Ingelheim Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Boehringer Ingelheim Opioid-induced Constipation Business Region Distribution
Table C.B. Fleet Information List
Table Product A Overview
Table Product B Overview
Table 2017 C.B. Fleet Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 C.B. Fleet Opioid-induced Constipation Business Region Distribution
Table Cosmo Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2017 Cosmo Pharmaceuticals Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Cosmo Pharmaceuticals Opioid-induced Constipation Business Region Distribution
Table Daewoong Information List
Table Product A Overview
Table Product B Overview
Table 2017 Daewoong Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Daewoong Opioid-induced Constipation Business Region Distribution
Table Daiichi Sankyo Information List
Table Product A Overview
Table Product B Overview
Table 2017 Daiichi Sankyo Opioid-induced Constipation Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Daiichi Sankyo Opioid-induced Constipation Business Region Distribution
Table GlaxoSmithKline Information List
Table Ironwood Pharmaceuticals Information List
Table Johnson & Johnson Information List
Table Merck Information List
Table Mundipharma Information List
Table Nektar Therapeutics Information List
Table Pfizer Information List
Table Progenics Pharmaceuticals Information List
Table Shionogi Information List
Table SLA Pharma Information List
Table Sucampo Information List
Table Synergy Pharmaceuticals Information List
Table Theravance Information List
Figure Global 2018-2025 Opioid-induced Constipation Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Opioid-induced Constipation Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Opioid-induced Constipation Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Opioid-induced Constipation Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Opioid-induced Constipation Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Opioid-induced Constipation Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Opioid-induced Constipation Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Opioid-induced Constipation Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Opioid-induced Constipation Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Opioid-induced Constipation by Type 2018-2025
Table Global Consumption Volume (K Units) of Opioid-induced Constipation by Application 2018-2025
Table Traders or Distributors with Contact Information of Opioid-induced Constipation by Region